
    
      This is a single center, multi dose, open label study assessing the delivery of Triferic AVNU
      administered intravenously to adult patients (> or equal to 18 years of age) using the
      Freedom Pump-20 during hemodialysis into the pre-dialyzer and post-dialyzer blood lines.
    
  